Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01125202 · ClinicalTrials.gov registry record · NA
Intervention to Reduce Dietary Sodium in Hemodialysis
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 179
- Enrollment target
NCT01125202: Completed NA study, sponsored by University of Pittsburgh.
NCT01125202 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 179 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01125202, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 179 participants
- Enrollment target
Study Summary
The purpose of this study is to test, in a randomized clinical trial of 200 hemodialysis patients, a behavioral intervention to reduce dietary sodium intake. The investigators will assess the impact on weight gain between dialysis treatments, blood pressures, symptoms, and health-related quality of life. The primary study hypotheses are that participants will gain less weight in between dialysis treatments, and that dietary recalls will demonstrate reduced consumption of dietary sodium.
Primary Outcome
Average interdialytic weight gains (kg/day) were calculated for the 1 week period prior to baseline measurement.
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL SCT-based behavioral intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-09 |
| Phase | NA |
What the finished NCT01125202 record still lists
NCT01125202 is an interventional study that assigns participants to a tested intervention. The registered 179 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Attention Control is the first listed.
NCT01125202 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01125202 about?
NCT01125202 is a clinical study titled "Intervention to Reduce Dietary Sodium in Hemodialysis". The purpose of this study is to test, in a randomized clinical trial of 200 hemodialysis patients, a behavioral intervention to reduce dietary sodium intake. The investigators will assess the impact on weight gain between dialysis treatments, blood pressures, symptoms, and health-related quality of ...
What is the current status of trial NCT01125202?
This trial is currently completed. It is a NA study. The enrollment target is 179 participants. The study started on 2009-09. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01125202?
The interventions under investigation include: Attention Control (BEHAVIORAL), SCT-based behavioral intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01125202?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01125202's enrollment target sits among peer trials
179 604th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06581198 · 179 participants · Phase 2
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
- NCT07356323 · 179 participants · NA
A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia